Global Market Report

Global Companion Diagnostics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Feb 13, 2019
  • PAGES：180
  • REPORT CODE：GMM163026
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Companion Diagnostics witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 Companion Diagnostics market is offered. The research provides insights for the global Companion Diagnostics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Companion Diagnostics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Companion Diagnostics Market Segmentations:

    By Players:

    • Thermo Fisher Scientific Inc. (U.S.

    • Abbott Laboratories (U.S.)

    • Myriad Genetics Inc. (U.S.)

    • QIAGEN N.V. (Netherlands)

    • Agilent Technologies (U.S.

    • Roche Diagnostics (Switzerland)


    By Types:

    • Polymerase Chain Reaction Test ( PCR)

    • Immunohistochemistry Test (IHC)

    • In Situ Hybridization Test (ISH)

    • Others


    By End-User:

    • Breast Cancer

    • Non-small Cell Lung Cancer (NSCLC)

    • Colorectal Cancer (CRC)

    • Melanoma Cancer

    • Gastric Cancer

    • Others


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Companion Diagnostics Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Companion Diagnostics Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Companion Diagnostics Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Companion Diagnostics Market Share by Types

      • 1.3.2 Global Companion Diagnostics Market Size and Growth Rate of Polymerase Chain Reaction Test ( PCR) from 2014 to 2026

      • 1.3.3 Global Companion Diagnostics Market Size and Growth Rate of Immunohistochemistry Test (IHC) from 2014 to 2026

      • 1.3.4 Global Companion Diagnostics Market Size and Growth Rate of In Situ Hybridization Test (ISH) from 2014 to 2026

      • 1.3.5 Global Companion Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Companion Diagnostics Market Share by End-Users

      • 1.4.2 Global Companion Diagnostics Market Size and Growth Rate of Breast Cancer from 2014 to 2026

      • 1.4.3 Global Companion Diagnostics Market Size and Growth Rate of Non-small Cell Lung Cancer (NSCLC) from 2014 to 2026

      • 1.4.4 Global Companion Diagnostics Market Size and Growth Rate of Colorectal Cancer (CRC) from 2014 to 2026

      • 1.4.5 Global Companion Diagnostics Market Size and Growth Rate of Melanoma Cancer from 2014 to 2026

      • 1.4.6 Global Companion Diagnostics Market Size and Growth Rate of Gastric Cancer from 2014 to 2026

      • 1.4.7 Global Companion Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 BelgiumCompanion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Companion Diagnostics Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Companion Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of Polymerase Chain Reaction Test ( PCR)

      • 3.4.2 Market Size and Growth Rate of Immunohistochemistry Test (IHC)

      • 3.4.3 Market Size and Growth Rate of In Situ Hybridization Test (ISH)

      • 3.4.4 Market Size and Growth Rate of Others


    4 Segmentation of Companion Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Companion Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Companion Diagnostics for Breast Cancer

      • 4.4.2 Market Size and Growth Rate of Companion Diagnostics for Non-small Cell Lung Cancer (NSCLC)

      • 4.4.3 Market Size and Growth Rate of Companion Diagnostics for Colorectal Cancer (CRC)

      • 4.4.4 Market Size and Growth Rate of Companion Diagnostics for Melanoma Cancer

      • 4.4.5 Market Size and Growth Rate of Companion Diagnostics for Gastric Cancer

      • 4.4.6 Market Size and Growth Rate of Companion Diagnostics for Others


    5 Market Analysis by Major Regions

    • 5.1 Global Companion Diagnostics Production Analysis by Major Regions

    • 5.2 Global Companion Diagnostics Consumption Analysis by Major Regions

    • 5.3 Global Companion Diagnostics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Companion Diagnostics Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Companion Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Companion Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Companion Diagnostics Production, Import, Consumption and Export Analysis


    6 Product Commodity of Companion Diagnostics Market in Major Countries

    • 6.1 Top 5 Export Countries in Companion Diagnostics market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Companion Diagnostics market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Companion Diagnostics market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Companion Diagnostics market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Companion Diagnostics market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Companion Diagnostics market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Companion Diagnostics Landscape Analysis

    • 7.1 North America Companion Diagnostics Landscape Analysis by Major Types

    • 7.2 North America Companion Diagnostics Landscape Analysis by Major End-Users

    • 7.3 North America Companion Diagnostics Landscape Analysis by Major Countries

      • 7.3.1 United States Companion Diagnostics Market Volume and Growth Rate

      • 7.3.2 Canada Companion Diagnostics Market Volume and Growth Rate

      • 7.3.3 Mexico Companion Diagnostics Market Volume and Growth Rate


    8 Europe Companion Diagnostics Landscape Analysis

    • 8.1 Europe Companion Diagnostics Landscape Analysis by Major Types

    • 8.2 Europe Companion Diagnostics Landscape Analysis by Major End-Users

    • 8.3 Europe Companion Diagnostics Landscape Analysis by Major Countries

      • 8.3.1 Germany Companion Diagnostics Market Volume and Growth Rate

      • 8.3.2 UK Companion Diagnostics Market Volume and Growth Rate

      • 8.3.3 France Companion Diagnostics Market Volume and Growth Rate

      • 8.3.4 Italy Companion Diagnostics Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Companion Diagnostics Market Volume and Growth Rate

      • 8.3.6 Spain Companion Diagnostics Market Volume and Growth Rate

      • 8.3.7 Belgium Companion Diagnostics Market Volume and Growth Rate

      • 8.3.8 Poland Companion Diagnostics Market Volume and Growth Rate

      • 8.3.9 Russia Companion Diagnostics Market Volume and Growth Rate

      • 8.3.10 Turkey Companion Diagnostics Market Volume and Growth Rate


    9 Asia Pacific Companion Diagnostics Landscape Analysis

    • 9.1 Asia Pacific Companion Diagnostics Landscape Analysis by Major Types

    • 9.2 Asia Pacific Companion Diagnostics Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Companion Diagnostics Landscape Analysis by Major Countries

      • 9.3.1 China Companion Diagnostics Market Volume and Growth Rate

      • 9.3.2 Japan Companion Diagnostics Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Companion Diagnostics Market Volume and Growth Rate

      • 9.3.4 India Companion Diagnostics Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Companion Diagnostics Market Volume and Growth Rate

      • 9.3.6 South Korea Companion Diagnostics Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Companion Diagnostics Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Companion Diagnostics Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Companion Diagnostics Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Companion Diagnostics Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Companion Diagnostics Market Volume and Growth Rate

      • 10.3.2 Brazil Companion Diagnostics Market Volume and Growth Rate

      • 10.3.3 Nigeria Companion Diagnostics Market Volume and Growth Rate

      • 10.3.4 South Africa Companion Diagnostics Market Volume and Growth Rate 

      • 10.3.5 Argentina Companion Diagnostics Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Thermo Fisher Scientific Inc. (U.S.

      • 11.1.1 Thermo Fisher Scientific Inc. (U.S. Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Abbott Laboratories (U.S.)

      • 11.2.1 Abbott Laboratories (U.S.) Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Myriad Genetics Inc. (U.S.)

      • 11.3.1 Myriad Genetics Inc. (U.S.) Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 QIAGEN N.V. (Netherlands)

      • 11.4.1 QIAGEN N.V. (Netherlands) Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Agilent Technologies (U.S.

      • 11.5.1 Agilent Technologies (U.S. Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Roche Diagnostics (Switzerland)

      • 11.6.1 Roche Diagnostics (Switzerland) Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 99 Figures and 151 Tables)

    • Figure Product Picture

    • Figure Global Companion Diagnostics Market Size and Growth Rate of Polymerase Chain Reaction Test ( PCR) from 2014 to 2026

    • Figure Global Companion Diagnostics Market Size and Growth Rate of Immunohistochemistry Test (IHC) from 2014 to 2026

    • Figure Global Companion Diagnostics Market Size and Growth Rate of In Situ Hybridization Test (ISH) from 2014 to 2026

    • Figure Global Companion Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Companion Diagnostics Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • Figure Global Companion Diagnostics Market Size and Growth Rate of Non-small Cell Lung Cancer (NSCLC) from 2014 to 2026

    • Figure Global Companion Diagnostics Market Size and Growth Rate of Colorectal Cancer (CRC) from 2014 to 2026

    • Figure Global Companion Diagnostics Market Size and Growth Rate of Melanoma Cancer from 2014 to 2026

    • Figure Global Companion Diagnostics Market Size and Growth Rate of Gastric Cancer from 2014 to 2026

    • Figure Global Companion Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Companion Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Companion Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Companion Diagnostics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Companion Diagnostics by Different Types from 2014 to 2026

    • Table Consumption Share of Companion Diagnostics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Polymerase Chain Reaction Test ( PCR)

    • Figure Market Size and Growth Rate of Immunohistochemistry Test (IHC)

    • Figure Market Size and Growth Rate of In Situ Hybridization Test (ISH)

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Companion Diagnostics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Companion Diagnostics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Non-small Cell Lung Cancer (NSCLC)

    • Figure Market Size and Growth Rate of Colorectal Cancer (CRC)

    • Figure Market Size and Growth Rate of Melanoma Cancer

    • Figure Market Size and Growth Rate of Gastric Cancer

    • Figure Market Size and Growth Rate of Others

    • Table Global Companion Diagnostics Production by Major Regions

    • Table Global Companion Diagnostics Production Share by Major Regions

    • Figure Global Companion Diagnostics Production Share by Major Regions in 2014

    • Figure Global Companion Diagnostics Production Share by Major Regions in 2018

    • Figure Global Companion Diagnostics Production Share by Major Regions in 2026

    • Table Global Companion Diagnostics Consumption by Major Regions

    • Table Global Companion Diagnostics Consumption Share by Major Regions

    • Figure Global Companion Diagnostics Consumption Share by Major Regions in 2014

    • Figure Global Companion Diagnostics Consumption Share by Major Regions in 2018

    • Figure Global Companion Diagnostics Consumption Share by Major Regions in 2026

    • Table North America Companion Diagnostics Production, Import, Consumption and Export Analysis

    • Table Europe Companion Diagnostics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Companion Diagnostics Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Companion Diagnostics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Companion Diagnostics market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Companion Diagnostics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Companion Diagnostics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Companion Diagnostics market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Companion Diagnostics Consumption by Types from 2014 to 2026

    • Table North America Companion Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure North America Companion Diagnostics Consumption Share by Types in 2014

    • Figure North America Companion Diagnostics Consumption Share by Types in 2018

    • Figure North America Companion Diagnostics Consumption Share by Types in 2026

    • Table North America Companion Diagnostics Consumption by End-Users from 2014 to 2026

    • Table North America Companion Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure North America Companion Diagnostics Consumption Share by End-Users in 2014

    • Figure North America Companion Diagnostics Consumption Share by End-Users in 2018

    • Figure North America Companion Diagnostics Consumption Share by End-Users in 2026

    • Table North America Companion Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table North America Companion Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Companion Diagnostics Consumption Share by Major Countries in 2014

    • Figure North America Companion Diagnostics Consumption Share by Major Countries in 2018

    • Figure North America Companion Diagnostics Consumption Share by Major Countries in 2026

    • Figure United States Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Companion Diagnostics Consumption by Types from 2014 to 2026

    • Table Europe Companion Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Europe Companion Diagnostics Consumption Share by Types in 2014

    • Figure Europe Companion Diagnostics Consumption Share by Types in 2018

    • Figure Europe Companion Diagnostics Consumption Share by Types in 2026

    • Table Europe Companion Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Europe Companion Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Companion Diagnostics Consumption Share by End-Users in 2014

    • Figure Europe Companion Diagnostics Consumption Share by End-Users in 2018

    • Figure Europe Companion Diagnostics Consumption Share by End-Users in 2026

    • Table Europe Companion Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Europe Companion Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Companion Diagnostics Consumption Share by Major Countries in 2014

    • Figure Europe Companion Diagnostics Consumption Share by Major Countries in 2018

    • Figure Europe Companion Diagnostics Consumption Share by Major Countries in 2026

    • Figure Germany Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure France Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Companion Diagnostics Consumption by Types from 2014 to 2026

    • Table Asia Pacific Companion Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Companion Diagnostics Consumption Share by Types in 2014

    • Figure Asia Pacific Companion Diagnostics Consumption Share by Types in 2018

    • Figure Asia Pacific Companion Diagnostics Consumption Share by Types in 2026

    • Table Asia Pacific Companion Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Companion Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Companion Diagnostics Consumption Share by End-Users in 2014

    • Figure Asia Pacific Companion Diagnostics Consumption Share by End-Users in 2018

    • Figure Asia Pacific Companion Diagnostics Consumption Share by End-Users in 2026

    • Table Asia Pacific Companion Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Companion Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Companion Diagnostics Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Companion Diagnostics Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Companion Diagnostics Consumption Share by Major Countries in 2026

    • Figure China Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandCompanion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure India Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Companion Diagnostics Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Companion Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Companion Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Companion Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Companion Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Companion Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Companion Diagnostics Consumption Share by Major Countries in 2026

    • Figure GCC Countries Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Companion Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Thermo Fisher Scientific Inc. (U.S.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific Inc. (U.S.

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific Inc. (U.S.

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific Inc. (U.S.

    • Table Product and Service Introduction of Thermo Fisher Scientific Inc. (U.S.

    • Table Company Profile and Development Status of Abbott Laboratories (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories (U.S.)

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories (U.S.)

    • Figure Revenue and Market Share Analysis of Abbott Laboratories (U.S.)

    • Table Product and Service Introduction of Abbott Laboratories (U.S.)

    • Table Company Profile and Development Status of Myriad Genetics Inc. (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics Inc. (U.S.)

    • Figure Sales and Growth Rate Analysis of Myriad Genetics Inc. (U.S.)

    • Figure Revenue and Market Share Analysis of Myriad Genetics Inc. (U.S.)

    • Table Product and Service Introduction of Myriad Genetics Inc. (U.S.)

    • Table Company Profile and Development Status of QIAGEN N.V. (Netherlands)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN N.V. (Netherlands)

    • Figure Sales and Growth Rate Analysis of QIAGEN N.V. (Netherlands)

    • Figure Revenue and Market Share Analysis of QIAGEN N.V. (Netherlands)

    • Table Product and Service Introduction of QIAGEN N.V. (Netherlands)

    • Table Company Profile and Development Status of Agilent Technologies (U.S.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies (U.S.

    • Figure Sales and Growth Rate Analysis of Agilent Technologies (U.S.

    • Figure Revenue and Market Share Analysis of Agilent Technologies (U.S.

    • Table Product and Service Introduction of Agilent Technologies (U.S.

    • Table Company Profile and Development Status of Roche Diagnostics (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics (Switzerland)

    • Figure Sales and Growth Rate Analysis of Roche Diagnostics (Switzerland)

    • Figure Revenue and Market Share Analysis of Roche Diagnostics (Switzerland)

    • Table Product and Service Introduction of Roche Diagnostics (Switzerland)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US